Total medical devices industry M&A deals worth $15.6bn were announced globally in Q3 2022, led by CVS Health’s $8bn acquisition of Signify Health, according to GlobalData’s deals database.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 173.7% over the previous quarter of $5.71bn and a drop of 38% when compared with the last four-quarter average, which stood at $25.19bn.
Comparing M&A deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $14.53bn. At the country level, the US topped the list in terms of deal value at $14.53bn.
In terms of volumes, North America emerged as the top region for medical devices industry M&A deals globally, followed by Europe and then Asia-Pacific.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe top country in terms of M&A deals activity in Q3 2022 was the US with 64 deals, followed by the UK with ten and Germany with eight.
In 2022, at the end of , M&A deals worth $28.82bn were announced globally in medical devices industry, marking a decrease of 58.9% year on year.
M&A deals in medical devices industry in Q3 2022: Top deals
The top five M&A deals in medical devices industry accounted for 58.9% of the overall value during Q3 2022.
The combined value of the top deals stood at $13.74bn, against the overall value of $15.6bn recorded for the quarter.
The top five medical devices industry medical devices deals of Q3 2022 tracked by GlobalData were:
1) CVS Health’s $8bn acquisition deal with Signify Health
2) The $3.9bn acquisition of 1Life Healthcare by Amazon.com
3) McKesson’s $875m acquisition deal with Rx Savings Solutions
4) The $500m acquisition of OpenEye Scientific Software by Cadence Design Systems
5) Azenta’s $468.22m acquisition deal with B Medical Systems
